149 related articles for article (PubMed ID: 552487)
1. Significance of malignant melanoma antigen (melanoma specific protein) in the urine.
Copeman PW; Cooke KB
J R Soc Med; 1979 Feb; 72(2):95-9. PubMed ID: 552487
[No Abstract] [Full Text] [Related]
2. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
Presser HJ; Morenz J; Höfs T; Zugehör M; Kühne KH; Brödemann M
Dermatol Monatsschr; 1987; 173(8):441-5. PubMed ID: 3311840
[No Abstract] [Full Text] [Related]
3. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.
Cui J; Bystryn JC
Arch Dermatol; 1995 Mar; 131(3):314-8. PubMed ID: 7887661
[TBL] [Abstract][Full Text] [Related]
4. Melanoma-associated hypopigmentation: where are the antibodies?
Merimsky O; Shoenfeld Y; Baharav E; Altomonte M; Chaitchik S; Maio M; Ferrone S; Fishman P
Am J Clin Oncol; 1996 Dec; 19(6):613-8. PubMed ID: 8931683
[TBL] [Abstract][Full Text] [Related]
5. Immunology and immunotherapy of human malignant melanoma.
Bystryn JC
Dermatol Clin; 1985 Apr; 3(2):327-34. PubMed ID: 2937585
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to normal human melanocytes in vitiligo.
Naughton GK; Eisinger M; Bystryn JC
J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
[TBL] [Abstract][Full Text] [Related]
7. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies to human melanoma cell in vitiligo by western blot analysis.
Hann SK; Kim JB
Yonsei Med J; 1995 Nov; 36(5):457-61. PubMed ID: 8546004
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation.
Naughton GK; Eisinger M; Bystryn JC
J Invest Dermatol; 1983 Dec; 81(6):540-2. PubMed ID: 6196421
[TBL] [Abstract][Full Text] [Related]
10. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
Garbelli S; Mantovani S; Palermo B; Giachino C
Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
[TBL] [Abstract][Full Text] [Related]
11. Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin?
Wankowicz-Kalinska A; Le Poole C; van den Wijngaard R; Storkus WJ; Das PK
Pigment Cell Res; 2003 Jun; 16(3):254-60. PubMed ID: 12753398
[TBL] [Abstract][Full Text] [Related]
12. [Detection of antibodies to melanoma cells in vitiligo by 125I-labeled SpA antibody binding assay].
Mori N; Shimada K; Satoh N; Nagao S; Iijima S; Kanzaki T
Nihon Hifuka Gakkai Zasshi; 1986 Jul; 96(8):835-8. PubMed ID: 3784053
[No Abstract] [Full Text] [Related]
13. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.
Mattes MJ; Thomson TM; Old LJ; Lloyd KO
Int J Cancer; 1983 Dec; 32(6):717-21. PubMed ID: 6197381
[TBL] [Abstract][Full Text] [Related]
14. Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.
Merimsky O; Shoenfeld Y; Yecheskel G; Chaitchik S; Azizi E; Fishman P
Cancer Immunol Immunother; 1994 Jun; 38(6):411-6. PubMed ID: 8205563
[TBL] [Abstract][Full Text] [Related]
15. Recognition of autoantigens by patients with melanoma.
Houghton AN; Vijayasaradhi S; Bouchard B; Naftzger C; Hara I; Chapman PB
Ann N Y Acad Sci; 1993 Aug; 690():59-68. PubMed ID: 8368771
[No Abstract] [Full Text] [Related]
16. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.
Yee C; Thompson JA; Roche P; Byrd DR; Lee PP; Piepkorn M; Kenyon K; Davis MM; Riddell SR; Greenberg PD
J Exp Med; 2000 Dec; 192(11):1637-44. PubMed ID: 11104805
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-tumour antibodies and auto-antibodies in vitiligo.
Woolfson H; Finn OA; Mackie RM; McQueen A; MacSween RN
Br J Dermatol; 1975 Apr; 92(4):395-400. PubMed ID: 1156553
[TBL] [Abstract][Full Text] [Related]
18. Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo.
Palermo B; Garbelli S; Mantovani S; Scoccia E; Da Prada GA; Bernabei P; Avanzini MA; Brazzelli V; Borroni G; Giachino C
Eur J Immunol; 2005 Nov; 35(11):3153-62. PubMed ID: 16224813
[TBL] [Abstract][Full Text] [Related]
19. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
[TBL] [Abstract][Full Text] [Related]
20. [Humoral and cellular autoimmunity in genuine vitiligo studied by means of an antigen produced from melanoma cells].
Höfs T
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):244-50. PubMed ID: 6179826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
